Transitioning from Part D to Part B: A Medicare Story

Author: Jeffrey L. Hymes, MD, CMO & SVP Following the U.S. Food and Drug Administration’s recent approval of Parsabiv™ (etelcalcetide),...

Intravenous Form of Sensipar® Has Been Approved by the FDA

Author: Jeffrey L. Hymes, MD, CMO & SVP Parsabiv™, an IV formulation similar to the oral calcimimetic Sensipar®, was recently...

2016 FreseniusRx Year in Review

At FreseniusRx, we understand that pharmacists are a critical part of our patients’ integrated care teams. Our pharmacists specialize in...

CMS Initiative Opens Door to Integrate Pharmacists into Patient Care

Patrick Wilson, R.Ph., BCACP, CDE The Centers for Medicare & Medicaid Services (CMS) launched an initiative in October 2015 in...

Integrated Care Likely to Improve ESRD Patient Outcomes

By Dr. Frank Maddux, Chief Medical Officer and Executive VP, Clinical and Scientific Affairs, at Fresenius Kidney Care North America...